Masimo Receives FDA Clearance For Noninvasive Total Hemoglobin

Get immediate results without having to send to the lab, and just overall from a patient view, this looks better than the way of drawing blood we are all accustomed to...with the usual needle and locating the vein to draw blood....BD

Masimo, the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion-and-Low-Perfusion pulse oximetry, announced it has received FDA clearance for its breakthrough noninvasive and continuous total hemoglobin monitoring technology (SpHb(TM)). The availability of Masimo SpHb technology should make hemoglobin measurement more convenient and broadly available to clinicians in both hospital and outpatient settings -- helping them make earlier and better clinical decisions, improve patient safety and decrease costs. Noninvasive total hemoglobin will be offered as part of the upgradable Masimo Rainbow SET technology platform.